Related Services Pharmaceutical Sciences and Formulation Salt Screening Formulation & Excipient Compatibility Related Insights Comprehensive Formulation Capabilities for Biopharmaceuticals Waiting to Inhale
Publication GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer (ACS Publications, 2021) Learn More
Publication Discovery of GLPG1972/S201086, a Potent, Selective, and Orally Bioavailable ADAMTS-5 Inhibitor for the Treatment of Osteoarthritis Learn More
